FIELD: medicine. SUBSTANCE: agent is made as suppository and has lipophilic fraction from rowan melanocarpous fruits pulp (7-20 wt.-%) and lipophilic suppository base up to 100. Agent shows antiinflammatory and analgetic activity. EFFECT: decreased treatment period. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR CHRONIC PROSTATITIS TREATMENT | 1995 |
|
RU2089211C1 |
METHOD TO TREAT CHRONIC UTERINE ADNEXA INFLAMMATIONS | 1996 |
|
RU2102061C1 |
METHOD OF TREATMENT OF CHRONIC PROSTATITIS | 1994 |
|
RU2097051C1 |
MEDICINAL AGENT FOR TREATING ENDOCERVICITIS | 1996 |
|
RU2112536C1 |
AGENT FOR TREATMENT OF PATIENTS WITH ADHESION PROCESS IN SMALL PELVIS | 1998 |
|
RU2139042C1 |
MEANS TO TREAT CHRONIC UTERINE ADNEXA INFLAMMATIONS | 1995 |
|
RU2104022C1 |
AGENT FOR CHRONIC PROSTATITIS HEALING | 2000 |
|
RU2179032C1 |
METHOD OF CHRONIC PROSTATITIS TREATMENT | 1993 |
|
RU2077889C1 |
METHOD OF TREATING CHRONIC PROSTATITIS AND PROSTATE ADENOMA | 2010 |
|
RU2435601C1 |
METHOD FOR TREATING THE CASES OF CHRONIC PROSTATITIS | 2001 |
|
RU2184543C1 |
Authors
Dates
1998-06-10—Published
1996-07-10—Filed